Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk.

Deckers JW, Goedhart DM, Boersma E, Briggs A, Bertrand M, Ferrari R, Remme WJ, Fox K, Simoons ML.

Eur Heart J. 2006 Apr;27(7):796-801. Epub 2006 Feb 23.

PMID:
16497685
2.

Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story.

Ferrari R, Fox K.

Drugs. 2009;69(3):265-77. doi: 10.2165/00003495-200969030-00003. Review.

PMID:
19275271
3.

Perindopril: a review of its use in patients with or at risk of developing coronary artery disease.

Curran MP, McCormack PL, Simpson D.

Drugs. 2006;66(2):235-55. Review.

PMID:
16451098
4.

Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.

Brugts JJ, Ferrari R, Simoons ML.

Expert Rev Cardiovasc Ther. 2009 Apr;7(4):345-60. doi: 10.1586/erc.09.2. Review. Erratum in: Expert Rev Cardiovasc Ther. 2009 Jun;7(6):722.

PMID:
19379059
5.

Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial.

Ferrari R, Bertrand ME, Remme WJ, Simoons ML, Deckers JW, Fox KM.

Expert Rev Cardiovasc Ther. 2007 Nov;5(6):1037-46. Review.

PMID:
18035919
6.

[Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].

Rapezzi C, Ciliberti P, Graziosi M, Riva L.

Ital Heart J. 2005 Nov;6 Suppl 7:40S-47S. Review. Italian.

PMID:
16485516
7.

Specific properties and effect of perindopril in controlling the renin-angiotensin system.

Ferrari R, Pasanisi G, Notarstefano P, Campo G, Gardini E, Ceconi C.

Am J Hypertens. 2005 Sep;18(9 Pt 2):142S-154S. Review.

PMID:
16125051
8.

Evidence for benefits of perindopril in hypertension and its complications.

Laurent S.

Am J Hypertens. 2005 Sep;18(9 Pt 2):155S-162S. Review.

PMID:
16125052
9.

Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.

Ferrari R.

Expert Rev Cardiovasc Ther. 2005 Jan;3(1):15-29. Review.

PMID:
15723572
10.

Perindopril: the reasonable choice in patients with coronary artery disease.

Cockcroft JR.

Int J Clin Pract. 2005 May;59(5):600-4. Review.

PMID:
15857358
11.

[Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].

Ferrari R, Papa K, Bernocchi P, Gimbatti OJ, Golcea SS, Bettini A, Ceconi C.

Ital Heart J. 2005 Nov;6 Suppl 7:24S-32S. Review. Italian.

PMID:
16485514
13.

EUROPA: has anything new been learned with angiotensin-converting enzyme inhibitors?

Sica DA.

J Clin Hypertens (Greenwich). 2004 Feb;6(2):91-5. Review.

14.

API expert consensus document on management of ischemic heart disease.

Association of Physicians of India.

J Assoc Physicians India. 2006 Jun;54:469-80. Review.

PMID:
16909697
15.

Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril/amlodipine.

Ferrari R.

Curr Med Res Opin. 2008 Dec;24(12):3543-57. doi: 10.1185/03007990802576302 . Review.

PMID:
19032136
16.

EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.

Simoons ML, Vos J, de Feyter PJ, Bots ML, Remme WJ, Grobbee DE, Kluft C, de Maat MP, Fox KM, Deckers JW.

Eur Heart J. 1998 Sep;19 Suppl J:J56-60. Review.

PMID:
9796842
17.

Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit.

Brugts JJ, Boersma E, Simoons ML.

Pharmacogenomics. 2010 Aug;11(8):1115-26. doi: 10.2217/pgs.10.103. Review.

PMID:
20712529
18.

Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy.

Brugts JJ, Danser AH, de Maat MP, den Uil CA, Boersma E, Ferrari R, Simoons ML.

Curr Opin Cardiol. 2008 Jul;23(4):296-301. doi: 10.1097/HCO.0b013e3283007ba6. Review.

PMID:
18520711
19.

Perindopril.

Alfakih K, Hall AS.

Expert Opin Pharmacother. 2006 Jan;7(1):63-71. Review.

PMID:
16370923
20.

The renin-angiotensin-aldosterone system: approaches to guide angiotensin-converting enzyme inhibition in patients with coronary artery disease.

Brugts JJ, den Uil CA, Danser AH, Boersma E.

Cardiology. 2009;112(4):303-12. doi: 10.1159/000159124. Epub 2008 Oct 2. Review.

PMID:
18832826

Supplemental Content

Support Center